“showed a trend”

The difference in the strain of l 1 was significant (P=0.028) between group 2 and group 1 and showed a trend toward statistical significance between group 2 and group 3 (P=0.052).

In low resource enclosures, fish abundance and mean chlorophyll- a concentrations over time showed a trend for a positive correlation to each other (Spearman's rank-order correlation, r s = 0.8, p = 0.052) and chlorophyll- a concentrations were in range with those found in Lake Krankesjön during the experimental time.

As shown in Table 4 , the T2 value in PZ was significantly correlated with age ( p = 0.024), while the T2 value in CZ showed a trend of correlation with age ( p = 0.052).

In the unmatched cohort, CRT showed a trend toward improved DMFS (median 101.38 months versus 50.16 months, P = 0.052) and DMFI (101.38 months versus 53.25 months, P = 0.071).

The univariate analysis showed a trend that patients without post-resection radiotherapy experienced longer OS than patients with post-resection radiotherapy [HR 0.48 (95% CI 0.23 to 1.01, p = 0.052)], which was not confirmed by multivariate analysis, with an adjusted HR of 0.90 (95% CI 0.37 to 2.20, p = 0.816).

Results A four-way ANOVA with group (ASD, ID, TD) as a between-subject factor and stimulus (face, car), direction (direct gaze/frontal view, downcast gaze/back view) and movement (dynamic, static) as within-subject factors showed a trend for interaction between all four main effects ( F (2, 31) = 3.264, p = 0.052, η p 2 = 0.174).

Cognitive distortions also showed a trend toward significance (p = .052), suggesting a potential role in reinforcing maladaptive beliefs around gambling outcomes.

At 12 months, patients showed a trend towards the highest efficacy in the 75% advancement group compared with the 60% and 90% groups ( H , 5.928; P = 0.052).

Resistant cell lines showed a trend toward a lower basal growth rate per day compared to sensitive cell lines (0.3 ± 0.06 vs . 0.5 ± 0.04, respectively; P = 0.052).

The application of full-dose cisplatin chemotherapy (≥ 200 mg per square meter body surface total dose) was significantly associated only with OS, and showed a trend towards significance for RFS ( p = 0.052, Table 3 ).

Despite the ANOVA result giving a p -value of over 0.05, it showed a trend that this factor had an effect on secoiridoid degradation ( p -value = 0.052).

Overall, we found that patients showed a trend to vary more in their within-task accuracy than controls [LME A3: Group t (100) = 1.97, P = 0.052].

A longer treatment duration showed a trend toward a greater reduction in CVAI ( r =0.331, P =0.052).

Specifically, the Trp/Tyr ratio was significantly lower in MIS lesions compared to BL (p = 0.030), while the Trp/Phe ratio showed a trend toward being lower in MIS compared to NL (p = 0.052). 3.3 Assessment of NL, BL, MIS, and MM skin barrier by resistance measurements Skin barrier integrity was evaluated through EIS measurements, determining skin resistance, i.e. , impedance (IZI) at 1kHz, for both NL and lesional skin, before (pre-sampling) and after (post-sampling) tape sampling.

Additionally, higher CUDIT‐R scores showed a weak association with lower Tp‐e/QTc (r=−0.220, P =0.019), and showed a trend toward a weak association with lower Tp‐e (r=−0.183, P =0.052) and Tp‐e/QT (r=−0.174, P =0.064).

Although graft localization showed a trend toward influencing outcomes, this did not reach statistical significance ( p = 0.052). 3.4.2.

Although no correlation was observed between the sCD163 levels and TNM stage in a Spearman’s rho correlation test ( p = 0.141), an intergroup analysis revealed that patients with TNM stage IV tumors showed a trend towards higher sCD163 levels compared to TNM stage 0/I patients ( p = 0.052, Figure 2 B).

Without these control variables, the results only showed a trend (p = 0.052).

Although PFS was comparable between the two groups, the TARE group showed a trend of prolonged PFS in a subpopulation of patients with Vp1 or Vp2 PVTT ( P =0.052).

PXN 200 also increased focus and satiety more than PLA ( p < 0.005) and showed a trend over PXN 300 ( p = 0.052), without affecting appetite ( p = 0.53).

Time to RT ≥ 49 days showed a trend for worse PFS in univariate testing (64.6% ± 9.1% vs 80.4% ± 2.2%; P = .052, Fig 2 C).

However, patients with UA showed a trend toward greater necrotic volume (9.4±3.8% vs. 7.5±3.7%, p =0.052) and less fibro-fatty tissue (15.1±8.1% vs. 18.3±7.6%, p =0.110) than SA patients.

After combining the patients and then subdividing into low NK and high NK groups, the patients in the high NK group showed a trend toward a higher implantation rate [20.4% (93/456) vs. 25.0% (126/505); P = 0.052] and abortion rate [20.3% (12/59) vs. 28.2% (22/78); P = 0.073] when compared with the low NK group.

Patients without AF recurrence showed a trend towards improvement in the palpitation score (p = 0.052) and global score (p = 0.062) at 12-month follow-up.

Comparing CSS and JBT Data Categories of CSSs were significantly associated with latency to the Nr-U probe (χ 2 = 6.07, df = 2.0, p = 0.048; Figure 4 ), and showed a trend towards association with the Nr-R probe (χ 2 = 5.90, df = 2.0, p = 0.052; Figure 5 ).